Results 271 to 280 of about 196,679 (336)

Análisis histórico de las Vasculitis, su clasificación y propuesta para su entendimiento

open access: diamond, 1993
Antonio Iglesias Gamarra   +4 more
openalex   +2 more sources

Effective Treatment of Livedoid Vasculopathy With Oral Tofacitinib

open access: yesClinical Case Reports, Volume 13, Issue 6, June 2025.
ABSTRACT We present a woman with severe refractory livedoid vasculopathy who was successfully treated with tofacitinib (5 mg twice a day). The ulcers gradually healed over a period of 2–3 months without experiencing any adverse events over a 1‐year follow‐up period.
Parvin Mansouri, Nikoo Mozafari
wiley   +1 more source

Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis

open access: green, 1990
Geoff K Frampton   +4 more
openalex   +2 more sources

Beyond Elimination: Unveiling Leprosy Cases in Far West Nepal

open access: yesClinical Case Reports, Volume 13, Issue 6, June 2025.
ABSTRACT Leprosy, one of the Neglected Tropical Diseases (NTDs), can be diagnosed based on any of its three characteristics: a hypopigmented or reddish skin patch with sensory loss, thickened peripheral nerves with sensory impairment, and a positive skin smear for acid‐fast bacilli (AFB).
Smriti Lama Thing   +5 more
wiley   +1 more source

LBO2 Long-term renal and cardiovascular risks of tacrolimus in lupus nephritis patients

open access: yesLupus Science and Medicine
Obbo W Bredewold   +6 more
doaj   +1 more source

Acute Ischemic Stroke in the Setting of Neurosarcoidosis

open access: yesClinical Case Reports, Volume 13, Issue 6, June 2025.
ABSTRACT We report a case of a 59‐year‐old male with a history of hypertension, polycythemia, and optic neuritis, who presented with progressive visual loss, bilateral lower extremity weakness, and new‐onset urinary and fecal incontinence. MRI findings of leptomeningeal enhancements raised suspicion for neurosarcoidosis, leading to initial treatment ...
Pichatorn Suppakitjanusant   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy